Each ingredient gets a tier from our researched dossier. The list sorts worst-first; the donut summarises the distribution. Tap any ingredient for its full dossier.
We treat each claim as a question — does what’s inside back it up? Tap a claim for the reasoning.
1/9
claims fully supported
“Debloat. Soothe. Digest.”unverified
Ingredient-based rationale exists (inulin, hing, fennel, caraway, peppermint, digestive enzymes) but the label itself states claims are 'based on scientific literature available on used ingredients' and the product 'is not intended to diagnose, treat, mitigate, cure or prevent any disease.' No product-level clinical trial is cited.
“Dual Action Multi Enzyme Blend”unverified
A five-enzyme blend is confirmed (Amylase, Protease, Lactase, Lipase, Cellulase). 'Dual action' is not defined on the label or in available data — the mechanism (enzymatic + herbal) is a plausible interpretation but is not explicitly substantiated.
“5 Digestive Enzymes”true
Confirmed by both the ingredient list and EXTRA INFORMATION keyIngredientDetails: Amylase, Protease, Lactase, Lipase, and Cellulase are all present in the Digestive Enzyme Blend at 100 mg per serving.
“Helps Reduce Occasional Gas”unverified
Asafoetida, fennel seed extract, caraway seed extract, and peppermint have established traditional and some clinical use as carminatives. However, no product-level randomised controlled trial is referenced, and the label disclaims disease-treatment intent.
“Helps Relieve Abdominal Discomfort”unverified
Individual ingredients (peppermint, fennel, caraway) have published evidence supporting relief of GI discomfort, but no product-level clinical outcome study is available in any of the four data sources.
“Fast-Acting Anti-Bloat Formula with Livaux® + Herbal Extracts”unverified
Livaux® (gold kiwi fruit, 100 mg per serving) and multiple herbal extracts (hing, fennel, caraway, peppermint) are confirmed present. 'Fast-acting' is a clinical outcome claim with no supporting study or timeframe cited in available data.
“Formulated for Seniors”unverified
The product is distributed by Antara Assisted Care Services Ltd., a known senior-living services company, and marketed under the AGEasy by Max Group sub-brand, consistent with a senior-oriented formulation intent. No specific nutrient adjustments for older adults are documented, but brand-level positioning supports the claim.
“Helps Relieve Bloating & Gas”unverified
Same basis as 'Helps Reduce Occasional Gas' — ingredient-level traditional and scientific rationale exists but no product-level clinical evidence is available in the data.
“Gentle and safe for daily use”misleading
The product's own label caveats state it is 'Not intended for use by pregnant or lactating women or anyone undergoing medical treatment.' Ingredient dossiers flag avoidance or caution for pregnancy, infants, lactation, IBS, epilepsy, G6PD deficiency, and multiple other groups. The claim overstates the universality of safety.
03 — The fuller picture
Read the whole thing if a one-line verdict isn’t enough.
Label explicitly excludes pregnant/lactating women and those under medical treatment
Who should approach with care
Pregnancy — Asafoetida has documented abortifacient/uterine-stimulant activity and fennel seed extract is not recommended by EMA HMPC during pregnancy due to estragole genotoxicity risk; the product label itself also explicitly excludes pregnant women.
Lactation — Asafoetida's bioactive sulfur compounds may transfer into breast milk, fennel extract is not recommended by EMA HMPC during breastfeeding, and concentrated digestive enzyme supplements lack adequate lactation safety data.
Infants — Peppermint menthol can cause reflex apnoea in infants; asafoetida has been linked to methemoglobinemia in infants; inulin is excluded from infant formulas by EU and FDA GRAS conditions; multiple other ingredients lack infant safety data.
Children — Fennel seed extract is restricted for children under 4 by EMA HMPC; steviol glycoside exposure at maximum levels can approach or exceed the ADI in younger children; malic acid contributes to dental enamel erosion risk.
Ibs — Inulin is a high-FODMAP fructan that is a well-documented IBS trigger; asafoetida and caraway may also irritate the GI mucosa, and malic acid can aggravate acid-sensitive IBS symptoms — ironic given this product targets bloating relief.
Ibd — High fermentable fiber from inulin may exacerbate gastrointestinal discomfort or inflammation during active IBD flares; medical guidance is recommended before use.
Epilepsy — Asafoetida contains ferulic acid and related compounds that may theoretically lower the seizure threshold in susceptible individuals per preliminary pharmacological literature.
Heart Disease — Asafoetida has reported anticoagulant properties that may interact with antiplatelet or anticoagulant medications; sodium from salt, though small per serving, adds to cumulative daily intake.
Hypertension — Common edible salt contributes sodium, and steviol glycosides may have mild blood-pressure-lowering interactions with antihypertensive medications at high intake; cumulative daily salt intake context matters.
Diabetes — FSSAI explicitly advises that non-sugar sweeteners including stevia are not recommended as a means of controlling blood glucose in individuals with diabetes, and some animal data suggest glycaemic effects at higher doses.
Kidney Disease — Salt adds to sodium load (restricted to ≤1,500 mg/day in CKD); gold kiwi fruit contributes potassium; L-leucine increases nitrogenous waste; silicon dioxide impurities (arsenic, lead) may accumulate with impaired renal clearance.
Liver Disease — Fennel seed extract contains estragole metabolised hepatically with potential for DNA adduct formation in impaired liver; concentrated peppermint oil has preclinical hepatotoxicity signals; L-leucine metabolism is substantially hepatic.
G6pd Deficiency — Menthol from peppermint extract can induce oxidative haemolysis in individuals with G6PD deficiency, particularly at concentrated supplemental doses present in this product.
Phenylketonuria — L-leucine is a branched-chain amino acid; individuals with PKU or other inborn errors of amino acid metabolism (e.g., maple syrup urine disease) require medical supervision of BCAA intake.
Gout — Natural Aam Panna flavour derived from raw mango contains fructose and organic acids; fructose-sensitive gout patients may wish to monitor intake even at flavouring quantities.
The full analysis
Bloat Calm is a low-calorie herbal-enzyme supplement aimed at older adults seeking daily digestive comfort — the AGEasy by Max Group branding and Antara Assisted Care distribution channel both target the senior demographic. The ingredient lineup is largely functional and grounded in traditional Indian digestive botanicals (hing, saunf, jeera), reinforced by a clinically studied prebiotic (Orafti® inulin) and a branded kiwi extract (Livaux®). However, the product is NOVA 4 ultra-processed owing to steviol glycoside, silicon dioxide (anti-caking agent), and enzyme isolates — categories rarely present in home kitchens. The single most important thing a consumer should know is that despite its 'gentle and safe for daily use' claim, the label's own caveats explicitly exclude pregnant and lactating women and anyone under medical treatment, and the inulin/FODMAP content means IBS sufferers should approach with real caution rather than expecting relief.
FSSAI licence
10020021005070
Manufacturer
Sundyota Numandis Probioceuticals Pvt. Ltd.
Region
IN
Source
MANUAL
Analysis
v1
Independently researched
Bloat Calm · AGEasy by Max Group / Wellbeing Nutrition | whatsinit